Charge-altering releasable transporters enhance mRNA delivery in vitro and exhibit in vivo tropism

The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies including the development of prophylactic and therapeutic vaccines, immunotherapies for cancer and strategies for genome editing. While polymers and oligome...

Full description

Saved in:
Bibliographic Details
Published in:Nature communications Vol. 14; no. 1; pp. 6983 - 15
Main Authors: Li, Zhijian, Amaya, Laura, Pi, Ruoxi, Wang, Sean K., Ranjan, Alok, Waymouth, Robert M., Blish, Catherine A., Chang, Howard Y., Wender, Paul A.
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01.11.2023
Nature Publishing Group
Nature Portfolio
Subjects:
13/1
13/106
13/109
13/21
13/31
140/131
140/58
59
59/5
631/61/54/152
639/638/298/54/152
639/638/455/941
64
64/60
Biomedical materials
Cancer vaccines
Carts
Gene Editing
Genome editing
Genomes
Humanities and Social Sciences
Immunotherapy
Lipids
Lymphocytes
Lymphocytes T
mRNA
multidisciplinary
Polymers
Protein expression
Proteins
RNA, Messenger - metabolism
Science
Science (multidisciplinary)
System effectiveness
T-Lymphocytes - metabolism
Transfection
Tropism
ISSN:2041-1723, 2041-1723
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies including the development of prophylactic and therapeutic vaccines, immunotherapies for cancer and strategies for genome editing. While polymers and oligomers have served as promising mRNA delivery systems, their efficacy in hard-to-transfect cells such as primary T lymphocytes is often limited as is their cell and organ tropism. To address these problems, considerable attention has been placed on structural screening of various lipid and cation components of mRNA delivery systems. Here, we disclose a class of charge-altering releasable transporters (CARTs) that differ from previous CARTs based on their beta-amido carbonate backbone (bAC) and side chain spacing. These bAC-CARTs exhibit enhanced mRNA transfection in primary T lymphocytes in vitro and enhanced protein expression in vivo with highly selective spleen tropism, supporting their broader therapeutic use as effective polyanionic delivery systems. Polymers are promising for mRNA delivery, but can have limited efficacy in hard to transfect cells. Here, the authors report charge-altering releasable transporters for improved mRNA transfection in primary T-lymphocytes and enhanced and selective protein expression in vivo.
AbstractList The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies including the development of prophylactic and therapeutic vaccines, immunotherapies for cancer and strategies for genome editing. While polymers and oligomers have served as promising mRNA delivery systems, their efficacy in hard-to-transfect cells such as primary T lymphocytes is often limited as is their cell and organ tropism. To address these problems, considerable attention has been placed on structural screening of various lipid and cation components of mRNA delivery systems. Here, we disclose a class of charge-altering releasable transporters (CARTs) that differ from previous CARTs based on their beta-amido carbonate backbone (bAC) and side chain spacing. These bAC-CARTs exhibit enhanced mRNA transfection in primary T lymphocytes in vitro and enhanced protein expression in vivo with highly selective spleen tropism, supporting their broader therapeutic use as effective polyanionic delivery systems.The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies including the development of prophylactic and therapeutic vaccines, immunotherapies for cancer and strategies for genome editing. While polymers and oligomers have served as promising mRNA delivery systems, their efficacy in hard-to-transfect cells such as primary T lymphocytes is often limited as is their cell and organ tropism. To address these problems, considerable attention has been placed on structural screening of various lipid and cation components of mRNA delivery systems. Here, we disclose a class of charge-altering releasable transporters (CARTs) that differ from previous CARTs based on their beta-amido carbonate backbone (bAC) and side chain spacing. These bAC-CARTs exhibit enhanced mRNA transfection in primary T lymphocytes in vitro and enhanced protein expression in vivo with highly selective spleen tropism, supporting their broader therapeutic use as effective polyanionic delivery systems.
The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies including the development of prophylactic and therapeutic vaccines, immunotherapies for cancer and strategies for genome editing. While polymers and oligomers have served as promising mRNA delivery systems, their efficacy in hard-to-transfect cells such as primary T lymphocytes is often limited as is their cell and organ tropism. To address these problems, considerable attention has been placed on structural screening of various lipid and cation components of mRNA delivery systems. Here, we disclose a class of charge-altering releasable transporters (CARTs) that differ from previous CARTs based on their beta-amido carbonate backbone (bAC) and side chain spacing. These bAC-CARTs exhibit enhanced mRNA transfection in primary T lymphocytes in vitro and enhanced protein expression in vivo with highly selective spleen tropism, supporting their broader therapeutic use as effective polyanionic delivery systems. Polymers are promising for mRNA delivery, but can have limited efficacy in hard to transfect cells. Here, the authors report charge-altering releasable transporters for improved mRNA transfection in primary T-lymphocytes and enhanced and selective protein expression in vivo.
The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies including the development of prophylactic and therapeutic vaccines, immunotherapies for cancer and strategies for genome editing. While polymers and oligomers have served as promising mRNA delivery systems, their efficacy in hard-to-transfect cells such as primary T lymphocytes is often limited as is their cell and organ tropism. To address these problems, considerable attention has been placed on structural screening of various lipid and cation components of mRNA delivery systems. Here, we disclose a class of charge-altering releasable transporters (CARTs) that differ from previous CARTs based on their beta-amido carbonate backbone (bAC) and side chain spacing. These bAC-CARTs exhibit enhanced mRNA transfection in primary T lymphocytes in vitro and enhanced protein expression in vivo with highly selective spleen tropism, supporting their broader therapeutic use as effective polyanionic delivery systems.
The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies including the development of prophylactic and therapeutic vaccines, immunotherapies for cancer and strategies for genome editing. While polymers and oligomers have served as promising mRNA delivery systems, their efficacy in hard-to-transfect cells such as primary T lymphocytes is often limited as is their cell and organ tropism. To address these problems, considerable attention has been placed on structural screening of various lipid and cation components of mRNA delivery systems. Here, we disclose a class of charge-altering releasable transporters (CARTs) that differ from previous CARTs based on their beta-amido carbonate backbone (bAC) and side chain spacing. These bAC-CARTs exhibit enhanced mRNA transfection in primary T lymphocytes in vitro and enhanced protein expression in vivo with highly selective spleen tropism, supporting their broader therapeutic use as effective polyanionic delivery systems. Polymers are promising for mRNA delivery, but can have limited efficacy in hard to transfect cells. Here, the authors report charge-altering releasable transporters for improved mRNA transfection in primary T-lymphocytes and enhanced and selective protein expression in vivo.
Abstract The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies including the development of prophylactic and therapeutic vaccines, immunotherapies for cancer and strategies for genome editing. While polymers and oligomers have served as promising mRNA delivery systems, their efficacy in hard-to-transfect cells such as primary T lymphocytes is often limited as is their cell and organ tropism. To address these problems, considerable attention has been placed on structural screening of various lipid and cation components of mRNA delivery systems. Here, we disclose a class of charge-altering releasable transporters (CARTs) that differ from previous CARTs based on their beta-amido carbonate backbone (bAC) and side chain spacing. These bAC-CARTs exhibit enhanced mRNA transfection in primary T lymphocytes in vitro and enhanced protein expression in vivo with highly selective spleen tropism, supporting their broader therapeutic use as effective polyanionic delivery systems.
ArticleNumber 6983
Author Waymouth, Robert M.
Pi, Ruoxi
Wang, Sean K.
Wender, Paul A.
Chang, Howard Y.
Li, Zhijian
Ranjan, Alok
Blish, Catherine A.
Amaya, Laura
Author_xml – sequence: 1
  givenname: Zhijian
  orcidid: 0000-0003-1849-1672
  surname: Li
  fullname: Li, Zhijian
  organization: Department of Chemistry, Stanford University
– sequence: 2
  givenname: Laura
  orcidid: 0000-0002-8742-9111
  surname: Amaya
  fullname: Amaya, Laura
  organization: Center for Personal Dynamic Regulomes, Stanford University, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
– sequence: 3
  givenname: Ruoxi
  orcidid: 0000-0002-2491-0979
  surname: Pi
  fullname: Pi, Ruoxi
  organization: Division of Infectious Diseases and Geographic Medicine, Department of Medicine
– sequence: 4
  givenname: Sean K.
  orcidid: 0000-0003-1557-8510
  surname: Wang
  fullname: Wang, Sean K.
  organization: Center for Personal Dynamic Regulomes, Stanford University, Department of Ophthalmology, Stanford University School of Medicine
– sequence: 5
  givenname: Alok
  orcidid: 0000-0001-9906-4044
  surname: Ranjan
  fullname: Ranjan, Alok
  organization: Department of Chemistry, Stanford University
– sequence: 6
  givenname: Robert M.
  orcidid: 0000-0001-9862-9509
  surname: Waymouth
  fullname: Waymouth, Robert M.
  organization: Department of Chemistry, Stanford University
– sequence: 7
  givenname: Catherine A.
  orcidid: 0000-0001-6946-7627
  surname: Blish
  fullname: Blish, Catherine A.
  organization: Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Chan Zuckerberg Biohub
– sequence: 8
  givenname: Howard Y.
  orcidid: 0000-0002-9459-4393
  surname: Chang
  fullname: Chang, Howard Y.
  organization: Center for Personal Dynamic Regulomes, Stanford University, Howard Hughes Medical Institute, Stanford University
– sequence: 9
  givenname: Paul A.
  orcidid: 0000-0001-6319-2829
  surname: Wender
  fullname: Wender, Paul A.
  email: wenderp@stanford.edu
  organization: Department of Chemistry, Stanford University, Department of Chemical and Systems Biology, Stanford University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37914693$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAUtFARLUv_AAcUiQuXgL-SOCdUrQpUqkBCcLaenZddrxJ7sbOr7b_H27TQ9lBfbL03Mx4_z2ty4oNHQt4y-pFRoT4lyWTdlJSLUvK64eXhBTnjVLKSNVycPDifkvOUNjQv0TIl5StyKpo2s1txRsxyDXGFJQwTRudXRcQBIYEZsJgi-LQNMXdSgX4N3mIx_vx-UXQ4uD3Gm8L5Yu-mGArwXYGHtTNumov7kPlh69L4hrzsYUh4frcvyO8vl7-W38rrH1-vlhfXpa0km0qpJG2NAWMBoRHY1rw2RnGGgFRVhvc1BSWajjXMdBV2RjWqYpb2YHvDpFiQq1m3C7DR2-hGiDc6gNO3hRBXGuLk7IC6xZr1rIFaVFK2plFCcq54b6ykSCuVtT7PWtudGbGz6PMwhkeijzverfUq7DWjNaecVlnhw51CDH92mCY9umRxGMBj2CXNlaryu2X-wAV5_wS6Cbvo86yOKNmKitI2o949tPTPy_1fZoCaATaGlCL22roJJheODt2QreljcvScHJ0v1rfJ0YdM5U-o9-rPksRMSttjcjD-t_0M6y_mGNcD
CitedBy_id crossref_primary_10_1016_j_jconrel_2024_11_038
crossref_primary_10_3389_fimmu_2023_1336187
crossref_primary_10_1038_s41467_025_62200_3
crossref_primary_10_2147_IJN_S527023
crossref_primary_10_1021_acsabm_5c00046
crossref_primary_10_1002_smsc_202400248
crossref_primary_10_3390_vaccines12070727
crossref_primary_10_1002_ange_202500306
crossref_primary_10_1016_j_it_2023_11_003
crossref_primary_10_1021_jacs_5c01389
crossref_primary_10_1021_jacs_4c02704
crossref_primary_10_1016_j_ymthe_2024_12_019
crossref_primary_10_1002_adma_202410998
crossref_primary_10_1016_j_jconrel_2024_10_028
crossref_primary_10_1088_1361_6528_ad7a03
crossref_primary_10_1002_anie_202500306
crossref_primary_10_1016_j_biomaterials_2024_122859
crossref_primary_10_1039_D4PY00124A
crossref_primary_10_1039_D4PY00206G
crossref_primary_10_3390_ijms242316938
crossref_primary_10_1039_D5TB00995B
crossref_primary_10_1128_aac_00201_24
crossref_primary_10_1002_adma_202407525
crossref_primary_10_1021_cbe_5c00031
Cites_doi 10.1002/bit.27686
10.1182/bloodadvances.2020002355
10.1158/0008-5472.CAN-18-2867
10.1016/j.immuni.2018.01.007
10.1016/j.jconrel.2018.02.043
10.3390/pharmaceutics13030396
10.1056/NEJMoa2107454
10.1016/j.omtn.2017.11.005
10.1038/s41467-020-19486-2
10.1016/j.ymthe.2018.03.010
10.1021/jacs.5b06355
10.1038/s41565-020-0669-6
10.1021/mp500581r
10.1016/j.ymthe.2021.06.004
10.1021/acs.biomac.8b00401
10.1073/pnas.2302191120
10.1021/acs.nanolett.8b01101
10.1073/pnas.1805358115
10.1056/NEJMoa2035389
10.1038/s41586-020-2537-9
10.1021/jacs.2c02706
10.1039/C9SC05267D
10.7150/thno.29678
10.1089/hum.2016.172
10.1038/nrd.2018.132
10.1038/s41392-022-00950-y
10.1016/j.ymthe.2017.06.008
10.1038/s41467-022-30896-2
10.1056/NEJMc2036242
10.1038/s41467-021-27434-x
10.1038/nm.3838
10.1016/j.biomaterials.2021.121339
10.1016/j.jconrel.2022.03.046
10.1146/annurev-bioeng-070620-033348
10.1021/acs.biomac.6b01463
10.1073/pnas.1614193114
10.1073/pnas.97.24.13003
10.1126/science.abm0594
10.1039/C8BM01262H
10.1038/s41565-019-0591-y
10.3390/vaccines9020097
10.1021/acscentsci.1c00361
10.1021/acs.nanolett.9b04246
10.1021/acsmacrolett.2c00060
10.1158/1078-0432.CCR-18-0432
10.1038/s41467-022-32281-5
10.1002/anie.202008082
10.1073/pnas.1810002115
10.1021/acs.biomac.2c00469
10.1021/jacs.9b03154
10.1021/jm0105676
10.1021/jacs.2c00273
10.1038/s41587-022-01393-0
ContentType Journal Article
Copyright The Author(s) 2023
2023. The Author(s).
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. The Author(s).
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-023-42672-x
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Computer Science Collection
ProQuest Central Essentials Local Electronic Collection Information
Biological Science Collection
ProQuest Central
Technology collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Databases
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
MEDLINE


Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: ProQuest Publicly Available Content
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 15
ExternalDocumentID oai_doaj_org_article_9e61f17a635449b78342282fbc40e058
PMC10620205
37914693
10_1038_s41467_023_42672_x
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
  grantid: 5R01CA245533-03
  funderid: https://doi.org/10.13039/100000054
– fundername: Emerson Collective
– fundername: NIDA NIH HHS
  grantid: DP1 DA046089
– fundername: ;
– fundername: ;
  grantid: 5R01CA245533-03
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LGEZI
LK8
LOTEE
M1P
M48
M7P
M~E
NADUK
NAO
NXXTH
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
AFFHD
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AZQEC
C1K
COVID
DWQXO
FR3
GNUQQ
H94
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
SOI
7X8
5PM
ID FETCH-LOGICAL-c541t-48409bbabcaea73e9626bb821eae085b2f60a837d171bd5edb87851c0facfb143
IEDL.DBID DOA
ISICitedReferencesCount 36
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001127178400024&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2041-1723
IngestDate Fri Oct 03 12:38:16 EDT 2025
Tue Nov 04 02:06:22 EST 2025
Sun Nov 09 13:39:18 EST 2025
Tue Oct 07 07:15:54 EDT 2025
Mon Jul 21 05:31:48 EDT 2025
Sat Nov 29 03:29:32 EST 2025
Tue Nov 18 21:58:37 EST 2025
Fri Feb 21 02:38:13 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2023. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c541t-48409bbabcaea73e9626bb821eae085b2f60a837d171bd5edb87851c0facfb143
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2491-0979
0000-0001-9906-4044
0000-0002-8742-9111
0000-0001-6319-2829
0000-0003-1849-1672
0000-0003-1557-8510
0000-0002-9459-4393
0000-0001-6946-7627
0000-0001-9862-9509
OpenAccessLink https://doaj.org/article/9e61f17a635449b78342282fbc40e058
PMID 37914693
PQID 2884935009
PQPubID 546298
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_9e61f17a635449b78342282fbc40e058
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10620205
proquest_miscellaneous_2885541402
proquest_journals_2884935009
pubmed_primary_37914693
crossref_citationtrail_10_1038_s41467_023_42672_x
crossref_primary_10_1038_s41467_023_42672_x
springer_journals_10_1038_s41467_023_42672_x
PublicationCentury 2000
PublicationDate 2023-11-01
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-01
  day: 01
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2023
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Wilk (CR34) 2020; 4
Gillmore (CR3) 2021; 385
Walker (CR53) 2017; 25
Ball, Hajj, Vizelman, Bajaj, Whitehead (CR8) 2018; 18
Haabeth (CR48) 2018; 115
Zhang (CR49) 2022; 144
Billingsley (CR25) 2020; 20
Olden, Cheng, Yu, Pun (CR27) 2018; 282
Haabeth (CR47) 2019; 79
Xue (CR15) 2022; 144
Campillo-Davo (CR20) 2021; 13
Ertl, High (CR21) 2017; 28
Venkataraman (CR40) 2017; 18
Li (CR18) 2021; 12
McKinlay (CR30) 2017; 114
Benner (CR36) 2019; 141
Jo (CR17) 2022; 13
Ni (CR50) 2022; 13
LoPresti, Arral, Chaudhary, Whitehead (CR14) 2022; 345
Kheirolomoom (CR22) 2022; 281
Rothbard (CR37) 2002; 45
Cheng (CR13) 2020; 15
CR5
Parayath, Stephan, Koehne, Nelson, Stephan (CR28) 2020; 11
Benner (CR7) 2018; 19
Parayath, Stephan (CR19) 2021; 23
Akinc (CR4) 2019; 14
Haabeth (CR33) 2021; 7
Hedrick, Piunova, Park, Erdmann, Arrechea (CR42) 2022; 11
Chen (CR12) 2019; 9
Sabnis (CR43) 2018; 26
Long (CR51) 2015; 21
McKinlay, Benner, Haabeth, Waymouth, Wender (CR31) 2018; 115
Wender, Huttner, Staveness, Vargas, Xu (CR38) 2015; 12
Amaya (CR32) 2023; 120
Testa (CR35) 2022; 23
Pastor (CR2) 2018; 17
Baden (CR9) 2021; 384
Olden, Cheng, Cheng, Pun (CR45) 2019; 7
Fang (CR1) 2022; 7
Harris, Zimmerman, Warga, Bamezai, Elmer (CR44) 2021; 118
Kumar, Connors, Farber (CR16) 2018; 48
Sahin (CR11) 2020; 585
Wender (CR41) 2000; 97
Blakney, Ip, Geall (CR6) 2021; 9
Rurik (CR23) 2022; 375
Kauffman (CR46) 2018; 10
Majzner (CR52) 2019; 25
Skowronski, De Serres (CR10) 2021; 384
Blake (CR29) 2020; 11
Tombácz (CR24) 2021; 29
Venkataraman (CR39) 2015; 137
Zhao (CR26) 2020; 59
PA Wender (42672_CR38) 2015; 12
42672_CR5
D Zhang (42672_CR49) 2022; 144
CJ McKinlay (42672_CR31) 2018; 115
PA Wender (42672_CR41) 2000; 97
S Venkataraman (42672_CR39) 2015; 137
JL Hedrick (42672_CR42) 2022; 11
A Kheirolomoom (42672_CR22) 2022; 281
TR Blake (42672_CR29) 2020; 11
JB Rothbard (42672_CR37) 2002; 45
OAW Haabeth (42672_CR47) 2019; 79
A Akinc (42672_CR4) 2019; 14
BR Olden (42672_CR45) 2019; 7
JG Rurik (42672_CR23) 2022; 375
MM Billingsley (42672_CR25) 2020; 20
NN Parayath (42672_CR28) 2020; 11
RG Majzner (42672_CR52) 2019; 25
AH Long (42672_CR51) 2015; 21
D Campillo-Davo (42672_CR20) 2021; 13
RL Ball (42672_CR8) 2018; 18
HCJ Ertl (42672_CR21) 2017; 28
AK Blakney (42672_CR6) 2021; 9
L Xue (42672_CR15) 2022; 144
OAW Haabeth (42672_CR33) 2021; 7
OAW Haabeth (42672_CR48) 2018; 115
S Jo (42672_CR17) 2022; 13
NN Parayath (42672_CR19) 2021; 23
E Harris (42672_CR44) 2021; 118
X Zhao (42672_CR26) 2020; 59
JD Gillmore (42672_CR3) 2021; 385
S Venkataraman (42672_CR40) 2017; 18
NL Benner (42672_CR7) 2018; 19
W Li (42672_CR18) 2021; 12
E Fang (42672_CR1) 2022; 7
S Sabnis (42672_CR43) 2018; 26
Q Cheng (42672_CR13) 2020; 15
BR Olden (42672_CR27) 2018; 282
F Pastor (42672_CR2) 2018; 17
BV Kumar (42672_CR16) 2018; 48
H Ni (42672_CR50) 2022; 13
DM Skowronski (42672_CR10) 2021; 384
L Amaya (42672_CR32) 2023; 120
LR Baden (42672_CR9) 2021; 384
S Testa (42672_CR35) 2022; 23
NL Benner (42672_CR36) 2019; 141
AJ Walker (42672_CR53) 2017; 25
KJ Kauffman (42672_CR46) 2018; 10
ST LoPresti (42672_CR14) 2022; 345
AJ Wilk (42672_CR34) 2020; 4
U Sahin (42672_CR11) 2020; 585
X Chen (42672_CR12) 2019; 9
I Tombácz (42672_CR24) 2021; 29
CJ McKinlay (42672_CR30) 2017; 114
References_xml – volume: 118
  start-page: 1693
  year: 2021
  end-page: 1706
  ident: CR44
  article-title: Nonviral gene delivery to T cells with Lipofectamine LTX
  publication-title: Biotechnol. Bioeng.
  doi: 10.1002/bit.27686
– volume: 4
  start-page: 4244
  year: 2020
  end-page: 4255
  ident: CR34
  article-title: Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy
  publication-title: Blood Adv.
  doi: 10.1182/bloodadvances.2020002355
– volume: 79
  start-page: 1624
  year: 2019
  end-page: 1634
  ident: CR47
  article-title: Local delivery of Ox40l, Cd80, and Cd86 mRNA kindles global anticancer immunity
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-18-2867
– volume: 48
  start-page: 202
  year: 2018
  end-page: 213
  ident: CR16
  article-title: Human T cell development, localization, and function throughout life
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.01.007
– volume: 282
  start-page: 140
  year: 2018
  end-page: 147
  ident: CR27
  article-title: Cationic polymers for non-viral gene delivery to human T cells
  publication-title: J. Control Release
  doi: 10.1016/j.jconrel.2018.02.043
– volume: 13
  start-page: 396
  year: 2021
  ident: CR20
  article-title: The ins and outs of messenger RNA electroporation for physical gene delivery in immune cell-based therapy
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics13030396
– volume: 385
  start-page: 493
  year: 2021
  end-page: 502
  ident: CR3
  article-title: CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJMoa2107454
– volume: 10
  start-page: 55
  year: 2018
  end-page: 63
  ident: CR46
  article-title: Rapid, single-cell analysis and discovery of vectored mRNA transfection in vivo with a loxP-flanked tdTomato reporter mouse
  publication-title: Mol. Ther. Nucleic Acids
  doi: 10.1016/j.omtn.2017.11.005
– volume: 11
  start-page: 6080
  year: 2020
  end-page: 17
  ident: CR28
  article-title: In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19486-2
– volume: 26
  start-page: 1509
  year: 2018
  end-page: 1519
  ident: CR43
  article-title: A novel amino lipid series for mrna delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2018.03.010
– volume: 137
  start-page: 13851
  year: 2015
  end-page: 13860
  ident: CR39
  article-title: A simple and facile approach to aliphatic N-substituted functional eight-membered cyclic carbonates and their organocatalytic polymerization
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.5b06355
– volume: 15
  start-page: 313
  year: 2020
  end-page: 320
  ident: CR13
  article-title: Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/s41565-020-0669-6
– volume: 12
  start-page: 742
  year: 2015
  end-page: 750
  ident: CR38
  article-title: Guanidinium-rich, glycerol-derived oligocarbonates: a new class of cell-penetrating molecular transporters that complex, deliver, and release siRNA
  publication-title: Mol. Pharm.
  doi: 10.1021/mp500581r
– volume: 29
  start-page: 3293
  year: 2021
  end-page: 3304
  ident: CR24
  article-title: Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2021.06.004
– volume: 19
  start-page: 2812
  year: 2018
  end-page: 2824
  ident: CR7
  article-title: Functional DNA delivery enabled by lipid-modified charge-altering releasable transporters (CARTs)
  publication-title: Biomacromolecules
  doi: 10.1021/acs.biomac.8b00401
– volume: 120
  start-page: e2302191120
  year: 2023
  ident: CR32
  article-title: Circular RNA vaccine induces potent T cell responses
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.2302191120
– volume: 18
  start-page: 3814
  year: 2018
  end-page: 3822
  ident: CR8
  article-title: Lipid nanoparticle formulations for enhanced co-delivery of siRNA and mRNA
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.8b01101
– volume: 115
  start-page: E5859
  year: 2018
  end-page: E5866
  ident: CR31
  article-title: Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1805358115
– volume: 384
  start-page: 403
  year: 2021
  end-page: 416
  ident: CR9
  article-title: Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine
  publication-title: New Engl. J. Med
  doi: 10.1056/NEJMoa2035389
– volume: 585
  start-page: 107
  year: 2020
  end-page: 112
  ident: CR11
  article-title: An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
  publication-title: Nature
  doi: 10.1038/s41586-020-2537-9
– volume: 144
  start-page: 9926
  year: 2022
  end-page: 9937
  ident: CR15
  article-title: Rational design of bisphosphonate lipid-like materials for mRNA delivery to the bone microenvironment
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.2c02706
– ident: CR5
– volume: 11
  start-page: 2951
  year: 2020
  end-page: 2966
  ident: CR29
  article-title: Synthesis and mechanistic investigations of pH-responsive cationic poly(aminoester)s
  publication-title: Chem. Sci.
  doi: 10.1039/C9SC05267D
– volume: 9
  start-page: 588
  year: 2019
  end-page: 607
  ident: CR12
  article-title: Circular RNAs in immune responses and immune diseases
  publication-title: Theranostics
  doi: 10.7150/thno.29678
– volume: 28
  start-page: 328
  year: 2017
  end-page: 337
  ident: CR21
  article-title: Impact of AAV capsid-specific T-cell responses on design and outcome of clinical gene transfer trials with recombinant adeno-associated viral vectors: an evolving controversy
  publication-title: Hum. Gene Ther.
  doi: 10.1089/hum.2016.172
– volume: 17
  start-page: 751
  year: 2018
  end-page: 767
  ident: CR2
  article-title: An RNA toolbox for cancer immunotherapy
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd.2018.132
– volume: 7
  start-page: 94
  year: 2022
  end-page: 31
  ident: CR1
  article-title: Advances in COVID-19 mRNA vaccine development
  publication-title: Signal Transduct. Target Ther.
  doi: 10.1038/s41392-022-00950-y
– volume: 25
  start-page: 2189
  year: 2017
  end-page: 2201
  ident: CR53
  article-title: Tumor antigen and receptor densities regulate efficacy of a chimeric antigen receptor targeting anaplastic lymphoma kinase
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2017.06.008
– volume: 13
  start-page: 3453
  year: 2022
  end-page: 16
  ident: CR17
  article-title: Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-022-30896-2
– volume: 384
  start-page: 1576
  year: 2021
  end-page: 1577
  ident: CR10
  article-title: Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJMc2036242
– volume: 12
  start-page: 7264
  year: 2021
  end-page: 12
  ident: CR18
  article-title: Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-27434-x
– volume: 21
  start-page: 581
  year: 2015
  end-page: 590
  ident: CR51
  article-title: 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
  publication-title: Nat. Med.
  doi: 10.1038/nm.3838
– volume: 281
  start-page: 121339
  year: 2022
  ident: CR22
  article-title: In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2021.121339
– volume: 345
  start-page: 819
  year: 2022
  end-page: 831
  ident: CR14
  article-title: The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs
  publication-title: J. Control Release
  doi: 10.1016/j.jconrel.2022.03.046
– volume: 23
  start-page: 385
  year: 2021
  end-page: 405
  ident: CR19
  article-title: In situ programming of CAR T cells
  publication-title: Annu. Rev. Biomed. Eng.
  doi: 10.1146/annurev-bioeng-070620-033348
– volume: 18
  start-page: 178
  year: 2017
  end-page: 188
  ident: CR40
  article-title: Amphiphilic and hydrophilic block copolymers from aliphatic N-substituted 8-membered cyclic carbonates: a versatile macromolecular platform for biomedical applications
  publication-title: Biomacromolecules
  doi: 10.1021/acs.biomac.6b01463
– volume: 114
  start-page: E448
  year: 2017
  end-page: E456
  ident: CR30
  article-title: Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1614193114
– volume: 97
  start-page: 13003
  year: 2000
  end-page: 13008
  ident: CR41
  article-title: The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.97.24.13003
– volume: 375
  start-page: 91
  year: 2022
  end-page: 96
  ident: CR23
  article-title: CAR T cells produced in vivo to treat cardiac injury
  publication-title: Science
  doi: 10.1126/science.abm0594
– volume: 7
  start-page: 789
  year: 2019
  end-page: 797
  ident: CR45
  article-title: Identifying key barriers in cationic polymer gene delivery to human T cells
  publication-title: Biomater. Sci.
  doi: 10.1039/C8BM01262H
– volume: 14
  start-page: 1084
  year: 2019
  end-page: 1087
  ident: CR4
  article-title: The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/s41565-019-0591-y
– volume: 9
  start-page: 97
  year: 2021
  ident: CR6
  article-title: An update on self-amplifying mRNA vaccine development
  publication-title: Vaccines
  doi: 10.3390/vaccines9020097
– volume: 7
  start-page: 1191
  year: 2021
  end-page: 1204
  ident: CR33
  article-title: An mRNA SARS-CoV-2 vaccine employing charge-altering releasable transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memory
  publication-title: ACS Cent. Sci.
  doi: 10.1021/acscentsci.1c00361
– volume: 20
  start-page: 1578
  year: 2020
  end-page: 1589
  ident: CR25
  article-title: Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR T cell engineering
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.9b04246
– volume: 11
  start-page: 368
  year: 2022
  end-page: 375
  ident: CR42
  article-title: Simple and efficient synthesis of functionalized cyclic carbonate monomers using carbon dioxide
  publication-title: ACS Macro Lett.
  doi: 10.1021/acsmacrolett.2c00060
– volume: 25
  start-page: 2560
  year: 2019
  end-page: 2574
  ident: CR52
  article-title: CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-18-0432
– volume: 13
  start-page: 4766
  year: 2022
  end-page: 4769
  ident: CR50
  article-title: Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-022-32281-5
– volume: 59
  start-page: 20083
  year: 2020
  end-page: 20089
  ident: CR26
  article-title: Imidazole-based synthetic lipidoids for in vivo mRNA delivery into primary T lymphocytes
  publication-title: Angew. Chem. Int. Ed. Engl.
  doi: 10.1002/anie.202008082
– volume: 115
  start-page: E9153
  year: 2018
  end-page: E9161
  ident: CR48
  article-title: mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1810002115
– volume: 23
  start-page: 2976
  year: 2022
  end-page: 2988
  ident: CR35
  article-title: Fingolimod-conjugated charge-altering releasable transporters efficiently and specifically deliver mRNA to lymphocytes in vivo and in vitro
  publication-title: Biomacromolecules
  doi: 10.1021/acs.biomac.2c00469
– volume: 141
  start-page: 8416
  year: 2019
  end-page: 8421
  ident: CR36
  article-title: Oligo(serine ester) charge-altering releasable transporters: organocatalytic ring-opening polymerization and their use for in vitro and in vivo mRNA delivery
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.9b03154
– volume: 45
  start-page: 3612
  year: 2002
  end-page: 3618
  ident: CR37
  article-title: Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake
  publication-title: J. Med. Chem.
  doi: 10.1021/jm0105676
– volume: 144
  start-page: 4746
  year: 2022
  end-page: 4753
  ident: CR49
  article-title: The unexpected importance of the primary structure of the hydrophobic part of one-component ionizable amphiphilic Janus dendrimers in targeted mRNA delivery activity
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.2c00273
– volume: 11
  start-page: 368
  year: 2022
  ident: 42672_CR42
  publication-title: ACS Macro Lett.
  doi: 10.1021/acsmacrolett.2c00060
– volume: 114
  start-page: E448
  year: 2017
  ident: 42672_CR30
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1614193114
– volume: 21
  start-page: 581
  year: 2015
  ident: 42672_CR51
  publication-title: Nat. Med.
  doi: 10.1038/nm.3838
– volume: 11
  start-page: 6080
  year: 2020
  ident: 42672_CR28
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19486-2
– volume: 115
  start-page: E9153
  year: 2018
  ident: 42672_CR48
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1810002115
– volume: 9
  start-page: 588
  year: 2019
  ident: 42672_CR12
  publication-title: Theranostics
  doi: 10.7150/thno.29678
– volume: 13
  start-page: 396
  year: 2021
  ident: 42672_CR20
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics13030396
– volume: 15
  start-page: 313
  year: 2020
  ident: 42672_CR13
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/s41565-020-0669-6
– volume: 384
  start-page: 403
  year: 2021
  ident: 42672_CR9
  publication-title: New Engl. J. Med
  doi: 10.1056/NEJMoa2035389
– volume: 384
  start-page: 1576
  year: 2021
  ident: 42672_CR10
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJMc2036242
– volume: 144
  start-page: 9926
  year: 2022
  ident: 42672_CR15
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.2c02706
– volume: 97
  start-page: 13003
  year: 2000
  ident: 42672_CR41
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.97.24.13003
– volume: 48
  start-page: 202
  year: 2018
  ident: 42672_CR16
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.01.007
– volume: 141
  start-page: 8416
  year: 2019
  ident: 42672_CR36
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.9b03154
– volume: 9
  start-page: 97
  year: 2021
  ident: 42672_CR6
  publication-title: Vaccines
  doi: 10.3390/vaccines9020097
– volume: 12
  start-page: 7264
  year: 2021
  ident: 42672_CR18
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-27434-x
– volume: 14
  start-page: 1084
  year: 2019
  ident: 42672_CR4
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/s41565-019-0591-y
– volume: 45
  start-page: 3612
  year: 2002
  ident: 42672_CR37
  publication-title: J. Med. Chem.
  doi: 10.1021/jm0105676
– volume: 118
  start-page: 1693
  year: 2021
  ident: 42672_CR44
  publication-title: Biotechnol. Bioeng.
  doi: 10.1002/bit.27686
– volume: 25
  start-page: 2189
  year: 2017
  ident: 42672_CR53
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2017.06.008
– volume: 7
  start-page: 94
  year: 2022
  ident: 42672_CR1
  publication-title: Signal Transduct. Target Ther.
  doi: 10.1038/s41392-022-00950-y
– volume: 29
  start-page: 3293
  year: 2021
  ident: 42672_CR24
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2021.06.004
– volume: 59
  start-page: 20083
  year: 2020
  ident: 42672_CR26
  publication-title: Angew. Chem. Int. Ed. Engl.
  doi: 10.1002/anie.202008082
– volume: 17
  start-page: 751
  year: 2018
  ident: 42672_CR2
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd.2018.132
– ident: 42672_CR5
  doi: 10.1038/s41587-022-01393-0
– volume: 10
  start-page: 55
  year: 2018
  ident: 42672_CR46
  publication-title: Mol. Ther. Nucleic Acids
  doi: 10.1016/j.omtn.2017.11.005
– volume: 281
  start-page: 121339
  year: 2022
  ident: 42672_CR22
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2021.121339
– volume: 19
  start-page: 2812
  year: 2018
  ident: 42672_CR7
  publication-title: Biomacromolecules
  doi: 10.1021/acs.biomac.8b00401
– volume: 345
  start-page: 819
  year: 2022
  ident: 42672_CR14
  publication-title: J. Control Release
  doi: 10.1016/j.jconrel.2022.03.046
– volume: 144
  start-page: 4746
  year: 2022
  ident: 42672_CR49
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.2c00273
– volume: 11
  start-page: 2951
  year: 2020
  ident: 42672_CR29
  publication-title: Chem. Sci.
  doi: 10.1039/C9SC05267D
– volume: 28
  start-page: 328
  year: 2017
  ident: 42672_CR21
  publication-title: Hum. Gene Ther.
  doi: 10.1089/hum.2016.172
– volume: 23
  start-page: 385
  year: 2021
  ident: 42672_CR19
  publication-title: Annu. Rev. Biomed. Eng.
  doi: 10.1146/annurev-bioeng-070620-033348
– volume: 120
  start-page: e2302191120
  year: 2023
  ident: 42672_CR32
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.2302191120
– volume: 115
  start-page: E5859
  year: 2018
  ident: 42672_CR31
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1805358115
– volume: 25
  start-page: 2560
  year: 2019
  ident: 42672_CR52
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-18-0432
– volume: 23
  start-page: 2976
  year: 2022
  ident: 42672_CR35
  publication-title: Biomacromolecules
  doi: 10.1021/acs.biomac.2c00469
– volume: 26
  start-page: 1509
  year: 2018
  ident: 42672_CR43
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2018.03.010
– volume: 20
  start-page: 1578
  year: 2020
  ident: 42672_CR25
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.9b04246
– volume: 282
  start-page: 140
  year: 2018
  ident: 42672_CR27
  publication-title: J. Control Release
  doi: 10.1016/j.jconrel.2018.02.043
– volume: 4
  start-page: 4244
  year: 2020
  ident: 42672_CR34
  publication-title: Blood Adv.
  doi: 10.1182/bloodadvances.2020002355
– volume: 79
  start-page: 1624
  year: 2019
  ident: 42672_CR47
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-18-2867
– volume: 18
  start-page: 3814
  year: 2018
  ident: 42672_CR8
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.8b01101
– volume: 585
  start-page: 107
  year: 2020
  ident: 42672_CR11
  publication-title: Nature
  doi: 10.1038/s41586-020-2537-9
– volume: 13
  start-page: 3453
  year: 2022
  ident: 42672_CR17
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-022-30896-2
– volume: 13
  start-page: 4766
  year: 2022
  ident: 42672_CR50
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-022-32281-5
– volume: 137
  start-page: 13851
  year: 2015
  ident: 42672_CR39
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.5b06355
– volume: 7
  start-page: 789
  year: 2019
  ident: 42672_CR45
  publication-title: Biomater. Sci.
  doi: 10.1039/C8BM01262H
– volume: 385
  start-page: 493
  year: 2021
  ident: 42672_CR3
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJMoa2107454
– volume: 375
  start-page: 91
  year: 2022
  ident: 42672_CR23
  publication-title: Science
  doi: 10.1126/science.abm0594
– volume: 12
  start-page: 742
  year: 2015
  ident: 42672_CR38
  publication-title: Mol. Pharm.
  doi: 10.1021/mp500581r
– volume: 18
  start-page: 178
  year: 2017
  ident: 42672_CR40
  publication-title: Biomacromolecules
  doi: 10.1021/acs.biomac.6b01463
– volume: 7
  start-page: 1191
  year: 2021
  ident: 42672_CR33
  publication-title: ACS Cent. Sci.
  doi: 10.1021/acscentsci.1c00361
SSID ssj0000391844
Score 2.568458
Snippet The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies including the...
Abstract The introduction of more effective and selective mRNA delivery systems is required for the advancement of many emerging biomedical technologies...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6983
SubjectTerms 13/1
13/106
13/109
13/21
13/31
140/131
140/58
59
59/5
631/61/54/152
639/638/298/54/152
639/638/455/941
64
64/60
Biomedical materials
Cancer vaccines
Carts
Gene Editing
Genome editing
Genomes
Humanities and Social Sciences
Immunotherapy
Lipids
Lymphocytes
Lymphocytes T
mRNA
multidisciplinary
Polymers
Protein expression
Proteins
RNA, Messenger - metabolism
Science
Science (multidisciplinary)
System effectiveness
T-Lymphocytes - metabolism
Transfection
Tropism
SummonAdditionalLinks – databaseName: Biological Science Database
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BAYkL70KgICNxg6iJYyfOCRVExWlVIZB6i_xKG6lNlk26av89M0421fLohWtiS5PMw9947PkA3vnaJ7zOeJxLmcfCC4NxMPdoyxgtE1Nw6UQgmygWC3V8XB5NG279dKxyExNDoHadpT3yfa6UKDOJkODj8mdMrFFUXZ0oNG7DHeqSwMPRvaN5j4W6nyshprsySab2exEiAy5UMS5NBY8vt9aj0Lb_b1jzzyOTv9VNw3J0-PB_P-QRPJiAKDsYLecx3PLtE7g3UlNePQVDdfgTH4dqOkrAiFxF93TRig1zQ_RVz3x7SobDzr8tDpjzZ3TO44o1LVs3w6pjunXMEwl3M4wP1x3O75ZNf_4Mfhx--f75azzxMcRWinSIBSWDxmhjtddF5ktMhoxRPPXaI3IzvM4TjQmvS4vUOOmdUQUCOpvU2tYGgdku7LRd618AM9YmrpTOGIQQIsu1zVPnpEF1KeqdHEG60Uplp2blxJlxVoWieaaqUZMVarIKmqwuI3g_z1mOrTpuHP2JlD2PpDbb4UG3Oqkmr61Kn6d1WmhEZUKUhkhJOOaotbEi8YlUEextdFxNvt9X1wqO4O38Gr2WSjG69d1FGCOJgD3hETwfLWuWJCtKFLbMIlBbNrcl6vabtjkNncExv-eI_2UEHzbmeS3Xv__Fy5s_4xXc5-Qx4QbmHuwMqwv_Gu7a9dD0qzfB5X4Bk5czvw
  priority: 102
  providerName: ProQuest
Title Charge-altering releasable transporters enhance mRNA delivery in vitro and exhibit in vivo tropism
URI https://link.springer.com/article/10.1038/s41467-023-42672-x
https://www.ncbi.nlm.nih.gov/pubmed/37914693
https://www.proquest.com/docview/2884935009
https://www.proquest.com/docview/2885541402
https://pubmed.ncbi.nlm.nih.gov/PMC10620205
https://doaj.org/article/9e61f17a635449b78342282fbc40e058
Volume 14
WOSCitedRecordID wos001127178400024&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Open Access Full Text
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: DOA
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Advanced Technologies & Aerospace Database
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: P5Z
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/hightechjournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: M7P
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central (subscription)
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: BENPR
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: 7X7
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Publicly Available Content
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: PIMPY
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BAYkL4k2grIzEDaImjh07xxa1ggOrqAJp4WLZjkMjtUm1SVftv2fsZJcuzwuXHPyIRjNjz4xmPB_Aa1e7hNYZjXPO85g5ZvAezB3qMt6WiRGUVyyATYj5XC4WRXkN6svXhI3tgUfG7RUuT-tUaDSMjBXG40JQDBNqY1niEh6e-SaiuBZMhTs4KzB0YdMrmSSTez0LdwKaqBiNkqDx5ZYlCg37f-dl_los-VPGNBiio_twb_Igyf5I-QO44dqHcGfElLx6BMYn0L-5OKTB8QfEo6Lo3r-QIsOmk_myJ6498RInZ8fzfVK5U1-gcUWalqyaYdkR3VbEefTsZhgHVx3u786b_uwxfD46_PTufTwBKcSWs3SImY_ijNHGaqdF5gqMYoyRNHXaoctlaJ0nGiPVKhWpqbirjBToidmk1rY26FE9gZ22a90zIMbapCp4ZQzafpbl2uZpVXGD3Ja-6XEE6Zqpyk5dxj3YxakK2e5MqlEQCgWhgiDUZQRvNnvOxx4bf1194GW1Wen7Y4cB1Bo1aY36l9ZEsLuWtJoOba-olKzIOHqdEbzaTONx8zkU3bruIqzhHjk9oRE8HRVjQ0kmCiS2yCKQWyqzRer2TNuchJbeGJhTdNx5BG_X2vWDrj_z4vn_4MULuEv9sQgPLHdhZ1heuJdw266Gpl_O4KZYiPCVM7h1cDgvj2fhrM18mWyJ35J_xZnyw8fyy3f16itV
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH4qUxBc2JdAASPBCaImjrMdECpL1VHbUYWKVE7BW9pIbTJM0qHzp_iNPDtLNSy99cA1sSPb-d7nZ_v5fQAvda49mgfUjcIwcplmAnkw0ohlZEtPxDRUzIpNxJNJcnCQ7q3Az_4ujAmr7DnRErWqpNkjX6dJwtIgRJfg3fS7a1SjzOlqL6HRwmJbL37gkq1-O_6I__cVpZuf9j9suZ2qgCtD5jcuM0saIbiQXPM40Cm69EIk1Ndco_8haB55HJdtyo99oUKtRGIE7KWXc5kLdC_wu1dglRmwj2B1b7y793XY1TH51hPGuts5XpCs18xyEU6NLk6GMXXPlmZAKxTwN-_2zyDN305q7QS4eet_G7rbcLNztclGaxt3YEWXd-FaK765uAfCRBocatfGC2CPiZGP4bW5SkaaIeX7rCa6PDKmQU4-TzaI0scmkmVBipLMi2ZWEV4qoo3MeNG0D-cV1q-mRX1yH75cSgcfwKisSv0IiJDSU2mohEAniQURl5GvVCgQHonJDu2A36Mgk106dqMKcpzZsIAgyVrkZIiczCInO3Pg9VBn2iYjubD0ewOuoaRJJG4fVLPDrOOlLNWRn_sxR7-TsVQY2RWKq_BcSOZpL0wcWOsxlXXsVmfngHLgxfAaeckcNvFSV6e2TGgk5j3qwMMWyUNLgjjFxqaBA8kSxpeauvymLI5s7nPfQwqhXujAm94cztv177F4fHE3nsP1rf3dnWxnPNl-AjeosVZ733QNRs3sVD-Fq3LeFPXsWWfwBL5dtqH8AukZlHQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6V8hAX3rSBAkaCE0TrOHYeB4QKZUVVtFohkCouaew4baQ2WTbp0v1r_DrGzqNaHr31wDVxIjv55vOMPZ4P4IXONWW5z9xAiMDlmkvkwUAjlpEtqQyZyLgVmwgnk2h_P56uwc_-LIxJq-w50RJ1VimzRj5iUcRjX6BLMMq7tIjpzvjt7LtrFKTMTmsvp9FCZE8vf2D4Vr_Z3cF__ZKx8Ycv7z-6ncKAqwT3Gpeb8EbKVKpUp6GvY3TvpYyYp1ONvohkeUBTDOEyL_RkJnQmIyNmr2ieqlyiq4HvvQJXQ4wxTTrhVHwb1ndM5fWI8-6cDvWjUc0tK-Ek6eK0GDL3bGUutJIBf_Nz_0zX_G3P1k6F49v_80e8A7c6B5xstxZzF9Z0eQ-ut5Kcy_sgTf7BoXZtFgGOnhhRmbQ2B8xIMxSCn9dEl0fGYMjJ58k2yfSxyW9ZkqIki6KZVyQtM6KN-HjRtBcXFT5fzYr65AF8vZQBPoT1sir1JhCpFM1ikUmJrhP3g1QFXpYJiVCJTM1oB7weEYnqirQbrZDjxCYL-FHSoihBFCUWRcmZA6-GZ2ZtiZILW78zQBtamvLi9kI1P0w6tkpiHXi5F6bojXIeSyPGwjA2z6XiVFMRObDV4yvpOK9OzsHlwPPhNrKV2YJKS12d2jbCCM9T5sBGi-qhJ34YY2dj34FoBe8rXV29UxZHtiK6R5FYGBUOvO5N47xf__4Wjy4exjO4gdaRfNqd7D2Gm8wYrj2EugXrzfxUP4FratEU9fyptXwCB5dtJb8Ar2ib1w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Charge-altering+releasable+transporters+enhance+mRNA+delivery+in+vitro+and+exhibit+in+vivo+tropism&rft.jtitle=Nature+communications&rft.au=Li%2C+Zhijian&rft.au=Amaya%2C+Laura&rft.au=Pi%2C+Ruoxi&rft.au=Wang%2C+Sean+K&rft.date=2023-11-01&rft.eissn=2041-1723&rft.volume=14&rft.issue=1&rft.spage=6983&rft_id=info:doi/10.1038%2Fs41467-023-42672-x&rft_id=info%3Apmid%2F37914693&rft.externalDocID=37914693
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon